Neurotoxin-Induced Rodent Models of Parkinson’s Disease: Benefits and Drawbacks
- 25 March 2021
- journal article
- review article
- Published by Springer Nature in Neurotoxicity Research
- Vol. 39 (3) , 897-923
Abstract
Parkinson’s disease (PD), the second most common neurodegenerative disorder, is characterized by cardinal motor impairments, including akinesia and tremor, as well as by a host of non-motor symptoms, including both autonomic and cognitive dysfunction. PD is associated with a death of nigral dopaminergic neurons, as well as the pathological spread of Lewy bodies, consisting predominantly of the misfolded protein alpha-synuclein. To date, only symptomatic treatments, such as levodopa, are available, and trials aiming to cure the disease, or at least halt its progression, have not been successful. Wong et al. (2019) suggested that the lack of effective therapy against neurodegeneration in PD might be attributed to the fact that the molecular mechanisms standing behind the dopaminergic neuronal vulnerability are still a major scientific challenge. Understanding these molecular mechanisms is critical for developing effective therapy. Thirty-five years ago, Calne and William Langston (1983) raised the question of whether biological or environmental factors precipitate the development of PD. In spite of great advances in technology and medicine, this question still lacks a clear answer. Only 5–15% of PD cases are attributed to a genetic mutation, with the majority of cases classified as idiopathic, which could be linked to exposure to environmental contaminants. Rodent models play a crucial role in understanding the risk factors and pathogenesis of PD. Additionally, well-validated rodent models are critical for driving the preclinical development of clinically translatable treatment options. In this review, we discuss the mechanisms, similarities and differences, as well as advantages and limitations of different neurotoxin-induced rat models of PD. In the second part of this review, we will discuss the potential future of neurotoxin-induced models of PD. Finally, we will briefly demonstrate the crucial role of gene-environment interactions in PD and discuss fusion or dual PD models. We argue that these models have the potential to significantly further our understanding of PD.Keywords
This publication has 268 references indexed in Scilit:
- Sensorimotor assessment of the unilateral 6-hydroxydopamine mouse model of Parkinson's diseaseBehavioural Brain Research, 2012
- Solvent exposures and parkinson disease risk in twinsAnnals of Neurology, 2011
- Gene–environment interactions: Key to unraveling the mystery of Parkinson's diseaseProgress in Neurobiology, 2011
- Mechanisms of rotenone-induced proteasome inhibitionNeuroToxicology, 2010
- Genetic Animal Models of Parkinson's DiseaseNeuron, 2010
- The organic cation transporter-3 is a pivotal modulator of neurodegeneration in the nigrostriatal dopaminergic pathwayProceedings of the National Academy of Sciences, 2009
- Intrastriatal lipopolysaccharide injection induces parkinsonism in C57/B6 miceJournal of Neuroscience Research, 2009
- Mitochondrial complex I inhibition is not required for dopaminergic neuron death induced by rotenone, MPP + , or paraquatProceedings of the National Academy of Sciences, 2008
- Behavioral and histopathological consequences of paraquat intoxication in mice: Effects of α‐synuclein over‐expressionSynapse, 2007
- Systemic LPS causes chronic neuroinflammation and progressive neurodegenerationGlia, 2007